Drug Metabolism and Pharmacokinetics

Title Publication Date Language Citations
Moment Analysis Program available on Microsoft Excel.1999/01/01English45
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (1) : Absorption, Distribution, Metabolism and Excretion in Rats1998/01/01English11
Statistical Assessment of Linear Pharmacokinetics in Clinical Pharmacological Studies.2001/01/01English11
Studies on the Pharmacokinetics of Ebselen in Rats (1): Absorption, Distribution, Metabolism and Excretion after Single Oral Administration.1997/01/01English9
Absorption, Distribution, Metabolism and Excretion of Tacrolimus(FK506) in the Rat.1998/01/01English8
Pharmacokinetics of 14C-Telmisartan. (1). Absorption, Distribution and Protein Binding of 14C-Telmisartan after a Single Oral Administration to Rats.1999/01/01English8
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (5). In Vitro Metabolism and Plasma Protein Binding in Animals and Human.1999/01/01English7
Ocular Tissue Distribution in Rabbit after Instillation of Bromfenac Sodium Ophthalmic Solution.1999/01/01English6
Production of SN-38, a Main Metabolite of the Camptothecin Derivative CPT-11, and Its Species and Tissue Specificities.1991/01/01English6
Studies on the metabolic disposition of ethyl eicosapentaenoate(EPA-E) in rats and dogs.1987/01/01English5
Pharmacokinetic Study of Capecitabine in Monkeys and Mice. Species Diffrences in Distribution of the Enzymes Responsible for its Activation to 5-FU.2000/01/01English5
Pharmacokinetic Studies of 3-Methyl-1-phenyl-2-pyrazolin-5-one(MCI-186): Metabolism in Rats, Dogs and Human.1996/01/01English5
Metabolic Fate of Fluvastatin, an Inhibitor of HMG-CoA Reductase. (1): Absorption, Distribution and Excretion of (14C)Fluvastatin after Single Administration in Rats.1995/01/01English5
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (2). Absorption, Distribution, Metabolism, Excretion and Accumulation Following Repeated Oral Administration of 14C-NK-104 in Rats.1998/01/01English5
Metabolic Fate of Losartan, a New Angiotensin II Receptor Antagonist. (1). Absorption, Distribution, Metabolism and Excretion after Single Administration in Rats.1995/01/01English4
Comparison of Tacrolimus (FK506) Levels Determined by Three Different Methods in the Rat Blood.1995/01/01English4
Studies on the Metabolic Fate of Ultra Short Acting .BETA.1 Blocker ONO-1101. (3). Metabolism and Protein Binding.1997/01/01English4
Metabolic fate of geranylgeranylacetone.1986/01/01English4
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (4). Interspecies Variation in Laboratory Animals and Humans.1999/01/01English4
Pharmacokinetic studies of 1.ALPHA., 24(R)-(OH)2D3(TV-02)(1). Plasma level, distribution metabolism and excretion after a single subcutaneous administration to rats.1990/01/01English4
Pharmacokinetic Studies of 3-Methyl-1-phenyl-2-pyrazolin-5-one(MCI-186) in Rats. (1). Blood and Plasma Levels, Distribution, Metabolism and Excretion after a Single Intravenous Administration.1996/01/01English4
Frequency Distribution of CYP2C19, CYP2D6, and CYP2C9 Mutant-alleles in Several Different Populations.2001/01/01English4
Mechanism for Production of Pharmacologically Active Metabolite of CS-747, A New Anti-Platelet Agent2001/01/01English4
Alleviation of Chlorpromazine-Photosensitized Contact Dermatitis by β-Cyclodextrin Derivatives and Their Possible Mechanisms1988/01/01English4
Studies on the Metabolic Fate of Flutamide. (1): Plasma Concentration after Single Administration and Protein Binding in Rats.1995/01/01English3
Metabolism of a New Bactericidal Antiseptic, OPB-2045, in Rats following Subcutaneous Administration.1998/01/01English3
Pharmacokinetics and biotransformation of beraprost sodium I: Plasma level profile of beraprost sodium in rat.1989/01/01English3
In Vitro Evaluation of Drug Interaction Caused by Enzyme Inhibition. HAB Protocol.2001/01/01English3
A Possible Mechanism of Lethal Interactions of the New Antiviral Drug, Sorivudine, with 5-Fluorouracil Prodrugs and Clinical Problems on Anti-cancer Chemotherapy.2000/01/01English3
Pharmacokinetic Studies of Suplatast tosilate (IPD-1151T). (I): Absorption, Distribution and Excretion after Administration of 14C-Suplatast tosilate (IPD-1151T) to Rats.1992/01/01English3